APO Research
Talk to an analyst

APO RESEARCH · REPORT

Developmental and Reproductive Toxicology (DART) Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Developmental and Reproductive Toxicology (DART) Services Market Outlook and Growth Opportunities 2026

12 August 2026197 pages

Choose your research edition.

Industry ResearchDevelopmental and Reproductive Toxicology (DART) Services Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Developmental and Reproductive Toxicology (DART) Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Developmental and Reproductive Toxicology (DART) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Developmental and Reproductive Toxicology (DART) Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Developmental and Reproductive Toxicology (DART) Services Market Analysis and Forecast 2026-2032174 pages · $4,950 USD

Market perspective

The global Developmental and Reproductive Toxicology (DART) Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Developmental and Reproductive Toxicology (DART) Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Developmental and Reproductive Toxicology (DART) Services market include AnaPath Services, Frontage, WuXi AppTec, Creative Animodel, Pharmaron, Labcorp, RCC, Creative Biolabs and IITRI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Developmental and Reproductive Toxicology (DART) Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Developmental and Reproductive Toxicology (DART) Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Developmental and Reproductive Toxicology (DART) Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Developmental and Reproductive Toxicology (DART) Services market.

Developmental and Reproductive Toxicology (DART) Services Segment by Company

AnaPath Services

Frontage

WuXi AppTec

Creative Animodel

Pharmaron

Labcorp

RCC

Creative Biolabs

IITRI

Syngene

JOINN

Inotiv

Accelera

Charles River

Developmental and Reproductive Toxicology (DART) Services Segment by Type

Fertility and Early Embryonic Development (FEED) study

Embryofetal Development (EFD) study

Pre- and Post-natal (PPND) study

Others

Developmental and Reproductive Toxicology (DART) Services Segment by Application

Biotechnology

Academic Research

Others

Developmental and Reproductive Toxicology (DART) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Developmental and Reproductive Toxicology (DART) Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Developmental and Reproductive Toxicology (DART) Services key companies, revenue, market share, and recent developments.

3. To split the Developmental and Reproductive Toxicology (DART) Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Developmental and Reproductive Toxicology (DART) Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Developmental and Reproductive Toxicology (DART) Services significant trends, drivers, influence factors in global and regions.

6. To analyze Developmental and Reproductive Toxicology (DART) Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Developmental and Reproductive Toxicology (DART) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Developmental and Reproductive Toxicology (DART) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Developmental and Reproductive Toxicology (DART) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Developmental and Reproductive Toxicology (DART) Services industry.

Chapter 3: Detailed analysis of Developmental and Reproductive Toxicology (DART) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Developmental and Reproductive Toxicology (DART) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Developmental and Reproductive Toxicology (DART) Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Developmental and Reproductive Toxicology (DART) Services Industry Trends Table 2. Developmental and Reproductive Toxicology (DART) Services Industry Drivers Table 3. Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges Table 4. Developmental and Reproductive Toxicology (DART) Services Industry Restraints Table 5. Global Developmental and Reproductive Toxicology (DART) Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Developmental and Reproductive Toxicology (DART) Services Revenue Share by Company (2021-2026) Table 7. Global Developmental and Reproductive Toxicology (DART) Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Developmental and Reproductive Toxicology (DART) Services Key Company Manufacturing Base & Headquarters Table 9. Global Developmental and Reproductive Toxicology (DART) Services Company, Product Type & Application Table 10. Global Developmental and Reproductive Toxicology (DART) Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Developmental and Reproductive Toxicology (DART) Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fertility and Early Embryonic Development (FEED) study Table 15. Significant Companies of Embryofetal Development (EFD) study Table 16. Significant Companies of Pre- and Post-natal (PPND) study Table 17. Significant Companies of Others Table 18. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type (2021-2026) Table 22. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Biotechnology Table 24. Significant Companies of Academic Research Table 25. Significant Companies of Others Table 26. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application (2021-2026) Table 30. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application (2027-2032) Table 31. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Region (2021-2026) Table 34. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Region (2027-2032) Table 36. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Market Share by Country (2021-2026) Table 39. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Market Share by Country (2027-2032) Table 41. AnaPath Services Company Information Table 42. AnaPath Services Business Overview Table 43. AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 45. AnaPath Services Recent Development Table 46. Frontage Company Information Table 47. Frontage Business Overview Table 48. Frontage Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 50. Frontage Recent Development Table 51. WuXi AppTec Company Information Table 52. WuXi AppTec Business Overview Table 53. WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 55. WuXi AppTec Recent Development Table 56. Creative Animodel Company Information Table 57. Creative Animodel Business Overview Table 58. Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 60. Creative Animodel Recent Development Table 61. Pharmaron Company Information Table 62. Pharmaron Business Overview Table 63. Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 65. Pharmaron Recent Development Table 66. Labcorp Company Information Table 67. Labcorp Business Overview Table 68. Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 70. Labcorp Recent Development Table 71. RCC Company Information Table 72. RCC Business Overview Table 73. RCC Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 75. RCC Recent Development Table 76. Creative Biolabs Company Information Table 77. Creative Biolabs Business Overview Table 78. Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 80. Creative Biolabs Recent Development Table 81. IITRI Company Information Table 82. IITRI Business Overview Table 83. IITRI Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 85. IITRI Recent Development Table 86. Syngene Company Information Table 87. Syngene Business Overview Table 88. Syngene Developmental and Reproductive Toxicology (DART) Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 90. Syngene Recent Development Table 91. JOINN Company Information Table 92. JOINN Business Overview Table 93. JOINN Developmental and Reproductive Toxicology (DART) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 95. JOINN Recent Development Table 96. Inotiv Company Information Table 97. Inotiv Business Overview Table 98. Inotiv Developmental and Reproductive Toxicology (DART) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 100. Inotiv Recent Development Table 101. Accelera Company Information Table 102. Accelera Business Overview Table 103. Accelera Developmental and Reproductive Toxicology (DART) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 105. Accelera Recent Development Table 106. Charles River Company Information Table 107. Charles River Business Overview Table 108. Charles River Developmental and Reproductive Toxicology (DART) Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio Table 110. Charles River Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Developmental and Reproductive Toxicology (DART) Services Product Image Figure 2. Global Developmental and Reproductive Toxicology (DART) Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Developmental and Reproductive Toxicology (DART) Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fertility and Early Embryonic Development (FEED) study Image Figure 8. Embryofetal Development (EFD) study Image Figure 9. Pre- and Post-natal (PPND) study Image Figure 10. Others Image Figure 11. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type (2021-2032) Figure 14. Biotechnology Image Figure 15. Academic Research Image Figure 16. Others Image Figure 17. Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application (2021-2032) Figure 20. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Fertility and Early Embryonic Development (FEED) study
  • Embryofetal Development (EFD) study
  • Pre- and Post-natal (PPND) study
  • Others
Applications
  • Biotechnology
  • Academic Research
  • Others
Companies covered
  • AnaPath Services
  • Frontage
  • WuXi AppTec
  • Creative Animodel
  • Pharmaron
  • Labcorp
  • RCC
  • Creative Biolabs
  • IITRI
  • Syngene
  • JOINN
  • Inotiv
  • Accelera
  • Charles River

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Developmental and Reproductive Toxicology (DART) Services Market Dynamics
  1. 2.1 Developmental and Reproductive Toxicology (DART) Services Industry Trends
  2. 2.2 Developmental and Reproductive Toxicology (DART) Services Industry Drivers
  3. 2.3 Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges
  4. 2.4 Developmental and Reproductive Toxicology (DART) Services Industry Restraints
3 Developmental and Reproductive Toxicology (DART) Services Market by Company
  1. 3.1 Global Developmental and Reproductive Toxicology (DART) Services Company Revenue Ranking in 2025
  2. 3.2 Global Developmental and Reproductive Toxicology (DART) Services Revenue by Company (2021-2026)
  3. 3.3 Global Developmental and Reproductive Toxicology (DART) Services Company Ranking (2024-2026)
  4. 3.4 Global Developmental and Reproductive Toxicology (DART) Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Developmental and Reproductive Toxicology (DART) Services Company Product Type and Application
  6. 3.6 Global Developmental and Reproductive Toxicology (DART) Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Developmental and Reproductive Toxicology (DART) Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Developmental and Reproductive Toxicology (DART) Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Developmental and Reproductive Toxicology (DART) Services Market by Type
  1. 4.1 Developmental and Reproductive Toxicology (DART) Services Type Introduction
  2. 4.1.1 Fertility and Early Embryonic Development (FEED) study
  3. 4.1.2 Embryofetal Development (EFD) study
  4. 4.1.3 Pre- and Post-natal (PPND) study
  5. 4.1.4 Others
  6. 4.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type
  7. 4.2.1 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type (2021-2032)
5 Developmental and Reproductive Toxicology (DART) Services Market by Application
  1. 5.1 Developmental and Reproductive Toxicology (DART) Services Application Introduction
  2. 5.1.1 Biotechnology
  3. 5.1.2 Academic Research
  4. 5.1.3 Others
  5. 5.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application
  6. 5.2.1 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application (2021-2032)
6 Developmental and Reproductive Toxicology (DART) Services Regional Value Analysis
  1. 6.1 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032)
  7. 6.3.2 North America Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032)
  10. 6.4.2 Europe Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032)
  16. 6.6.2 South America Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Country, 2025 VS 2032
7 Developmental and Reproductive Toxicology (DART) Services Country-level Value Analysis
  1. 7.1 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Developmental and Reproductive Toxicology (DART) Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Developmental and Reproductive Toxicology (DART) Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Developmental and Reproductive Toxicology (DART) Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AnaPath Services
  2. 8.1.1 AnaPath Services Company Information
  3. 8.1.2 AnaPath Services Business Overview
  4. 8.1.3 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  6. 8.1.5 AnaPath Services Recent Developments
  7. 8.2 Frontage
  8. 8.2.1 Frontage Company Information
  9. 8.2.2 Frontage Business Overview
  10. 8.2.3 Frontage Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  12. 8.2.5 Frontage Recent Developments
  13. 8.3 WuXi AppTec
  14. 8.3.1 WuXi AppTec Company Information
  15. 8.3.2 WuXi AppTec Business Overview
  16. 8.3.3 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  18. 8.3.5 WuXi AppTec Recent Developments
  19. 8.4 Creative Animodel
  20. 8.4.1 Creative Animodel Company Information
  21. 8.4.2 Creative Animodel Business Overview
  22. 8.4.3 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  24. 8.4.5 Creative Animodel Recent Developments
  25. 8.5 Pharmaron
  26. 8.5.1 Pharmaron Company Information
  27. 8.5.2 Pharmaron Business Overview
  28. 8.5.3 Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  30. 8.5.5 Pharmaron Recent Developments
  31. 8.6 Labcorp
  32. 8.6.1 Labcorp Company Information
  33. 8.6.2 Labcorp Business Overview
  34. 8.6.3 Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  36. 8.6.5 Labcorp Recent Developments
  37. 8.7 RCC
  38. 8.7.1 RCC Company Information
  39. 8.7.2 RCC Business Overview
  40. 8.7.3 RCC Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  42. 8.7.5 RCC Recent Developments
  43. 8.8 Creative Biolabs
  44. 8.8.1 Creative Biolabs Company Information
  45. 8.8.2 Creative Biolabs Business Overview
  46. 8.8.3 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  48. 8.8.5 Creative Biolabs Recent Developments
  49. 8.9 IITRI
  50. 8.9.1 IITRI Company Information
  51. 8.9.2 IITRI Business Overview
  52. 8.9.3 IITRI Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  54. 8.9.5 IITRI Recent Developments
  55. 8.10 Syngene
  56. 8.10.1 Syngene Company Information
  57. 8.10.2 Syngene Business Overview
  58. 8.10.3 Syngene Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  60. 8.10.5 Syngene Recent Developments
  61. 8.11 JOINN
  62. 8.11.1 JOINN Company Information
  63. 8.11.2 JOINN Business Overview
  64. 8.11.3 JOINN Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  66. 8.11.5 JOINN Recent Developments
  67. 8.12 Inotiv
  68. 8.12.1 Inotiv Company Information
  69. 8.12.2 Inotiv Business Overview
  70. 8.12.3 Inotiv Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  72. 8.12.5 Inotiv Recent Developments
  73. 8.13 Accelera
  74. 8.13.1 Accelera Company Information
  75. 8.13.2 Accelera Business Overview
  76. 8.13.3 Accelera Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  78. 8.13.5 Accelera Recent Developments
  79. 8.14 Charles River
  80. 8.14.1 Charles River Company Information
  81. 8.14.2 Charles River Business Overview
  82. 8.14.3 Charles River Developmental and Reproductive Toxicology (DART) Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio
  84. 8.14.5 Charles River Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst